Binding of dimethylarsinous acid to Cys-13α of rat hemoglobin is responsible for the retention of arsenic in rat blood

Chemical Research in Toxicology

Volumn 20, Issue 1, 2007, Pages 27-37

  Lu, Meiling ^a   Wang, Hailin ^a   Li, Xing Fang ^a   Arnold, Lora L ^b   Cohen, Samuel M ^b   Le, X Chris ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC DERIVATIVE; CACODYLIC ACID; CYSTEINE; DIMETHYLARSINOUS ACID; HEMOGLOBIN; INORGANIC COMPOUND; METHANEARSONIC ACID; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARSENIC POISONING; ARTICLE; BINDING SITE; BODY WEIGHT; CHEMICAL BINDING; CONTROLLED STUDY; ERYTHROCYTE; FLUID INTAKE; FOOD INTAKE; HYPERPLASIA; METHYLATION; NONHUMAN; PROTEIN BINDING; RAT; STOICHIOMETRY; TOXICOKINETICS; TRACE METAL BLOOD LEVEL; URETHRA DISEASE;

AMINO ACID SEQUENCE; ANIMALS; ARSENIC; BINDING SITES; CACODYLIC ACID; CHROMATOGRAPHY, GEL; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE; FEMALE; HEMOGLOBINS; RATS; RATS, INBRED F344; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

RATTUS;

EID: 33846854172     PISSN: 0893228X     EISSN: None     Source Type: Journal    
DOI: 10.1021/tx060195+     Document Type: Article

References (75)

1. IARC (International Agency for Research on Cancer). (1980) Some Metals and Metallic Compounds. In: IARC. Monographs on the Evaluation of the Carcinogenic Risks to Humans. World Health Organization, Lyon, France.
2. NRC (National Research Council). (2001) Arsenic in the Drinking Water (update). National Academy Press, Washington, D.C.
3. Chen, C. J., Chuang, Y. C., Lin, T. M., and Wu, H. Y. (1985) Malignant neoplasms among residents of a blackfoot disease endemic area in Taiwan-high arsenic artesian well water and cancers. Cancer Res. 45, 5895-5899.
4. Chiou, H. Y., Chiou, S. T., Hsu, Y. H., Chou, Y. L., Tseng, C. H., Wei, M. L., and Chen, C. J. (2001) Incidence of transitional cell carcinoma and arsenic in drinking water: a follow-up of 8,012 residents in an arseniasis-endemic area in northeastern Taiwan. Am. J. Epidemiol. 153, 411-418.
5. Smith, A. H., Goycolea, M., Haque, R., and Biggs, M. L. (1998) Marked increase in bladder and lung cancer mortality in a region of Northern Chile due to arsenic in drinking water. Am. J. Epidemiol. 147, 660-669.
6. Abernathy, C. O., Liu, Y. P., Longfellow, D., Aposhian, H. V., Beck, B. D., Fowler, B. A., Goyer, R. A., Menzer, R., Rossman, T., Thompson, C., and Waalkes, M. (1999) Arsenic: health effects, mechanisms of actions, and research issues. Environ. Health Perspect. 107, 593-597.
7. Nordstrom, D. K. (2002) Worldwide occurrences of arsenic in ground water. Science 296, 2143-2145.
8. Chakraborti, D., Rahman, M. M., Paul, K., Chowdhury, U. K., Sengupta, M. K., Lodh, D., Chanda, C. R., Saha, K. C., and Mukherjee, S. C. (2002) Arsenic calamity in the Indian subcontinent: What lessons have been learned? Talanta 58, 3-22.
9. Waalkes, M. P., Liu, J., Ward, J. M., and Diwan, B. A. (2004) Animal models for arsenic carcinogenesis: inorganic arsenic is a transplacental carcinogen in mice. Toxicol. Appl. Pharmacol. 198, 377-384.
10. Aposhian, H. V., and Aposhian, M. M. (2006) Arsenic toxicology: Five questions. Chem. Res. Toxicol. 19, 1-15.
11. Kitchin, K. T. (2001) Recent advances in arsenic carcinogenesis: modes of action, animal model systems, and methylated arsenic metabolites. Toxicol. Appl. Pharmacol. 172, 249-261.
12. Rosen, B. P. (2002) Biochemistry of arsenic detoxification. FEBS Lett. 529, 86-92.
13. Miller, W. H., Schipper, H. M., Lee, J. S., Singer, J., and Waxman, S. (2002) Mechanisms of action of arsenic trioxide. Cancer Res. 62, 3893-3903.
14. Styblo, M., Drobna, Z., Jaspers, I., Lin, S., and Thomas, D. J. (2002) The role of biomethylation in toxicity and carcinogenicity of arsenic: A research update. Environ. Health Perspect. 110, 767-777.
15. Rossman, T. G. (2003) Mechanism of arsenic carcinogenesis: an integrated approach. Mutat. Res. 533, 37-65.
16. Rossman, T. G., Uddin, A. N., Burns, F. J., and Bosland, M. C. (2001) Arsenite is a cocarcinogen with solar ultraviolet radiation for mouse skin: An animal model for arsenic carcinogenesis. Toxicol. Appl. Pharmacol. 176, 64-71.
17. Nishikawa, T., Wanibuchi, H., Ogawa, M., Kinoshita, A., Morimura, K., Hiroi, T., Funae, Y., Kishida, H., Nakae, D., and Fukushima, S. (2002) Promoting effects of monomethylarsonic acid, dimethylarsinic acid and trimethylarsine oxide on induction of rat liver preneoplastic glutathione S-transferase placental form positive foci: A possible reactive oxygen species mechanism. Int. J. Cancer 100, 136-139.
18. Waalkes, M. P., Ward, J. M., and Diwan, B. A. (2004) Induction of tumors of the liver, lung, ovary and adrenal in adult mice after brief maternal gestational exposure to inorganic arsenic: Promotional effects of postnatal phorbol ester exposure on hepatic and pulmonary, but not dermal cancers. Carcinogenesis 25, 133-141.
19. Yamamoto, S., Konishi, Y., Matsuda, T., Murai, T., Shibata, M. A., Matsuiyuasa, I., Otani, S., Kuroda, K., Endo, G., and Fukushima, S. (1995) Cancer induction by an organic arsenic compound, dimethylarsinic acid (cacodylic acid), in F344/DuCrj rats after pretreatment with five carcinogens. Cancer Res. 55, 1271-1276.
20. Xie, Y. X., Trouba, K. J., Liu, J., Waalkes, M. P., and Germolec, D. R. (2004). Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Haras transgenic (Tg.AC) mice. Environ. Health Perspect. 112, 1255-1263.
21. Patterson, R., Vega, L., Trouba, K., Bortner, C., and Germolec, D. (2004) Arsenic-induced alterations in the contact hypersensitivity response in Balb/c mice. Toxicol. Appl. Pharmacol. 198, 434-443.
22. Waalkes, M. P., Liu, J., Chen, H., Xie, Y., Achanzar, W. E., Shou, Y. -S., Cheng, M. -L., and Diwan, B. A. (2004) Estrogen signaling in livers of male mice with hepatocellular carcinoma induced by exposure to arsenic in utero. J. Natl. Cancer Inst. 96, 466-474.
23. Waalkes, M. P., Liu, J,, Ward, J. M., Powell, D. A., and Diwan, B. A. (2006) Urogenital carcinogenesis in female CD1 mice induced by in utero arsenic exposure is exacerbated by postnatal diethylstilbestrol treatment. Cancer Res. 66, 1337-1345.
24. Cohen, S. M., Arnold, L. L., Uzvolgyi, E., St. John, M., Yamamoto, S., Lu, X., and Le, X. C. (2002) Possible role of dimethylarsinous acid in dimethylarsinic acid-induced urothelial toxicity and regeneration in the rat. Chem. Res. Toxicol. 15, 1150-1157.
25. Wei, M., Wanibuchi, H., Yamamoto, S., Li, W., and Fukushima, S. (1999) Urinary bladder carcinogenicity of dimethylarsinic acid in male F344 rats. Carcinogenesis 20, 1873-1876.
26. Wei, M., Wanibuchi, H., Morimura, K., Iwai, S., Yoshida, K., Endo, G., Nakae, D., and Fukushima, S. (2002) Carcinogenicity of dimethylarsinic acid in male F344 rats and genetic alterations in induced urinary bladder tumors. Carcinogenesis 23, 1387-1397.
27. Cohen, S. M., Yamamoto, S., Cano, M., and Arnold, L. L. (2001) Urothelial cytotoxicity and regeneration induced by dimethylarsinic acid in rats. Toxicol. Sci. 59, 68-74.
28. Wanibuchi, H., Salim, E. I., Kinoshita, A., Shen, J., Wei, M., Morimura, K., Yoshida, K., Kuroda, K., Endo, G., and Fukushima, S. (2004) Understanding arsenic carcinogenicity by the use of animal models. Toxicol. Appl. Pharmacol. 198, 366-376.
29. Shen, J., Wanibuchi, H., Waalkes, M. P., Salim, E. I., Kinoshita, A., Yoshida, K., Endo, G., and Fukushima, S. (2006) A comparative study of the sub-chronic toxic effects of three toxic arsenical compounds on the urothelium in F344 rats; gender-based differences in response. Toxicol. Appl. Pharmacol. 210, 171-180.
30. 74As. Toxicol. Appl. Pharmacol. 53, 550-556.
31. Odanaka, Y., Matano, O., and Goto, S. (1980) Biomethylation of inorganic arsenic by the rat and some laboratory animals. Bull. Environ. Contam. Toxicol. 24, 452-459.
32. Buchet, J. P., Lauwerys, R., and Roels, H. (1981) Comparison of the urinary-excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in man. Int. Arch. Occup. Environ. Health 48, 71-79.
33. Lerman, S. A., and Clarkson, T. W. (1983) The metabolism of arsenite and arsenate by the rat. Fundam. Appl. Toxicol. 3, 309-314.
34. Vanter, M., Marafante, E., and Dencker, L. (1984) Tissue distribution and retention of As-74-dimethylarsenic acid in mice and rats. Arch. Environ. Contam. Toxicol. 13, 259-264.
35. Hughes, M. F., Del Razo, L. M., and Kenyon, E. M. (2000) Dose-dependent effects on tissue distribution and metabolism of dimethylarsinic acid in the mouse after intravenous administration. Toxicology 143, 155-166.
36. Winski, S. L., and Carter, D. E. (1995) Interactions of rat red blood cell sulfhydryls with arsenate and arsenite. J. Toxicol. Environ. Health 46, 379-397.
37. Delnomdedieu, M., Basti, M. M., Styblo, M., Otvos, J. D., and Thomas, D. J. (1994) Complexation of arsenic species in rabbit erythrocytes. Chem. Res. Toxicol. 7, 621-627.
38. Lu, M., Wang, H., Li, X. -F., Lu, X., Cullen, W. R., Arnold, L. L, Cohen, S. M., and Le, X. C. (2004) Evidence of hemoglobin binding to arsenic as a basis for the accumulation of arsenic in rat blood. Chem. Res. Toxicol. 17, 1733-1742.
39. Basu, A., Mahata, J., Gupta, S., and Gin, A. K. (2001) Genetic toxicology of a paradoxical human carcinogen, arsenic: a review. Mutat. Res. 488, 171-194.
40. Kitchin, K. T., and Ahmad, S. (2003) Oxidative stress as a possible mode of action for arsenic carcinogenesis. Toxicol. Lett. 137, 3-13.
41. Nesnow, S., Roop, B. C., Lambert, G., Kadiiska, M., Mason, R. P., Cullen, W. R., and Mass, M. J. (2002) DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem. Res. Toxicol. 15, 1627-1634.
42. Ahmad, S., Kitchin, K. T., and Cullen, W. R. (2002) Plasmid DNA damage caused by methylated arsenicals, ascorbic acid and human liver ferritin. Toxicol. Lett. 133, 47-57.
43. Kato, K., Yamanaka, K., Hasegawa, A., and Okada, S. (2003) Active arsenic species produced by GSH-dependent reduction of dimethylarsinic acid cause micronuclei formation in peripheral reticulocytes of mice. Mutat. Res. 539, 55-63.
44. Kligerman, A. D., Doerr, C. L., Tenant, A. H., Harrington-Brock, K., Allen, J. W., Winkfield, E., Poorman-Allen, P., Kundu, B., Funasaka, K., Roop, B. C., Mass, M. J., and DeMarini, D. M. (2003) Methylated trivalent arsenicals as candidate ultimate genotoxic forms of arsenic: Induction of chromosomal mutations but not gene mutations. Environ. Mol. Mutagen 42, 192-205.
45. Liu, S. X., Athar, M., Lippai, I., Waldren, C., and Hei, T. K. (2001) Induction of oxyradicals by arsenic: Implication for mechanism of genotoxicity. Proc. Natl. Acad. Sci. U.S.A. 98, 1643-1648.
46. Liu, S. X., Davidson, M. M., Tang, X., Walker, W. F., Athar, M., Ivanov, V., and Hei, T. K. (2005) Mitochondreal damage mediates genotoxicity of arsenic in mammalian cells. Cancer Res. 65, 3236-3242.
47. Schwerdtle, T., Walter, I., and Hartwig, A. (2003) Arsenite and its biomethylated metabolites interfere with the formation and repair of stable BPDE-induced DNA adducts in human cells and impair XPAzf and Fpg. DNA Repair 2, 1449-1463.
48. Styblo, M., Del Razo, L. M., Vega, L., Germolec, D. R., LeCluyse, E. L., Hamilton, G. A., Reed, W., Wang, C., Cullen, W. R., and Thomas, D. J. (2000) Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch. Toxicol. 74, 289-299.
49. Aposhian, H. V., Zakharyan, R. A., Avram, M. D., Kopplin, M. J., and Wollenberg, M. L. (2003) Oxidation and detoxification of trivalent arsenic species. Toxicol. Appl. Pharmacol. 193, 1-8.
50. Petrick, J. S., Jagadish, B., Mash, E. A., and Aposhian, H. V. (2001) Monomethylarsonous acid [MMA(III)] and arsenite: LD50 in hamsters and in vitro inhibition of pyruvate dehydrogenase. Chem. Res. Toxicol. 14, 651-656.
51. Styblo, M., Serves, S. V., Cullen, W. R., and Thomas, D. J. (1997) Comparative inhibition of yeast glutathione reductase by arsenicals and arsenothiols. Chem. Res. Toxicol. 10, 27-33.
52. Schuliga, M., Chouchane, S., and Snow, E. T. (2002) Upregulation of glutathione-related genes and enzyme activities in cultured human cells by sublethal concentrations of inorganic arsenic. Toxicol. Sci. 70, 183-192.
53. Chang, K. N., Lee, T. C., Tam, M. F., Chen, Y. C., Lee, L. W., Lee, S. Y., Lin, P. J., and Huang, R. N. (2003) Identification of galectin I and thioredoxin peroxidase II as two arsenic-binding proteins in Chinese hamster ovary cells. Biochem. J. 371, 495-503.
54. Cohen, S. M., Fisher, M. J., Sakata, T., Cano, M., Schoenig, G. P., Chappel, C. I., and Garland, E. M. (1990) Comparative analysis of the proliferative response to the rat urinary bladder to sodium saccharin by light and scanning electron microscopy and autoradiography. Scanning Microsc. 4, 135-142.
55. Cohen, S. M. (1983) Pathology of Experimental Bladder Cancer in Rodents. In The Pathology of Bladder Cancer (Cohen, S. M., and Bryan, G. T., Eds.) Vol. II, pp 1-40, CRC Press, Boca Raton, FL.
56. Le, X. C., Lu, X., Ma, M., Cullen, W. R., Aposhian, H. V., and Zheng, B. (2000) Speciation of key arsenic metabolic intermediates in human urine. Anal. Chem. 72, 5172-5177.
57. Le, X. C., Lu, X., and Li, X. -F. (2004) Arsenic speciation. Anal. Chem. 76, 27A-33A.
58. Jiang, G., Gong, Z., Li, X. -F., Cullen, W. R., and Le, X. C. (2003) Interaction of trivalent arsenicals with metallothionein. Chem. Res. Toxicol. 16, 873-880.
59. Gong, Z., Lu, X., Cullen, W. R., and Le, X. C. (2001) Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid. J. Anal At. Spectrom. 16, 1409-1413.
60. McLafferty, F. W., Fridriksson, E. K., Horn, D. M., Lewis, M. A., and Zubarev, R. A. (1999) Biochemistry-biomolecule mass spectrometry. Science 284, 1289-1290.
61. Aebersold, R. D., and Goodlett, D. R. (2001) Mass spectrometry in proteomics. Chem. Rev. 101, 269-296.
62. Bogdanov, B., and Smith, R. D. (2005) Proteomics by FTICR mass spectrometry: top down and bottom up. Mass Spectrom. Rev. 24, 168-200.
63. Challenger, F. (1945) Biological methylation. Chem. Rev. 36, 315-361.
64. Arnold, L. L., Cano, M., Margaret, St. J., Eldan, M., van Gemert, M., and Cohen, S. M. (1999) Effects of dietary dimethylarsinc acid on the urine and urothelium of rats. Carcinogenesis 20, 2171-2179.
65. Ahmad, S., Kitchin, K. T., and Cullen, W. R. (2000) Arsenic species that cause release of iron from ferritin and generation of activated oxygen. Arch. Biochem. Biophys. 382, 195-202.
66. Florea, A. M., Yamoah, E. N., and Dopp, E. (2005) Intracellular calcium disturbances induced by arsenic and its methylated derivatives in relation to genomic damage and apoptosis induction. Environ. Health Perspect. 113, 659-664.
67. Felix, K., Manna, S. K., Wise, K., Barr, K., Barr, J., and Ramesh, G. T. (2005) Low levels of arsenite activates nuclear factor-kappa B and activator protein-1 in immortalized mesencephalic cells. J. Biochem. Mol. Toxicol. 19, 67-77.
68. Sordo, M., Herrera, L. A., Ostrosky-Wegman, P., and Rojas, E. (2001) Cytotoxic and genotoxic effects of As, MMA, and DMA on leukocytes and stimulated human lymphocytes. Teratog., Carcinog., Mutagen 21, 249-260.
69. Schwerdlt, T., Walter, I., Mackiw, I., and Hartwig, A. (2003) Induction of oxidative DNA damage by arsenite and its trivalent and pentavalent methylated metabolites in cultured human cells and isolated DNA. Carcinogenesis 24, 967-974.
70. Dopp, E., Hartmann, L. M., Florea, A. M., von Rechlinghausen, U., Pieper, R., and Shokouhi, B. (2004) Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effect in Chinese hamster ovary (CHO) cells. Toxicol. Appl. Pharmacol. 201, 156-165.
71. Berlin, N. I., and Berk, P. D. (1974) The Biological Life of the Red Cell. In The Red Blood Cell (Surgenor, D. M., Ed.) Vol. II, pp 992, Academic Press, New York.
72. Shen, J., Wanibuchi, H., Salim, E. I., Wei, M., Doi, K., Yoshida, K., Endo, G., Morimura, K., and Fukushima, S. (2003) Induction of glutathione S-transferase placental form positive foci in liver and epithelial hyperplasia in urinary bladder, but no tumor development in male Fischer 344 rats treated with monomethylarsonic acid for 104 weeks. Toxicol. Appl. Pharmacol. 193, 335-345.
73. Hunter, F. T., Kip, A. F., and Irvine, J. W. (1942) Radioactive tracer studies on arsenic injected as potassium arsenate. I. Excretion and localization in tissues. J. Pharmacol. Exp. Ther. 76, 207-20.
74. 74 as a tracer. Univ. Calif. Publ. Pharmacol. 2, 263-282.
75. Fuentes, N., Zambrano, F., and Rosenmann, M. (1981) Arsenic contamination: metabolic effects and localization in rats. Comp. Biochem. Physiol., C 70, 269-272.